X‐Ray Spectroscopy on Biological Systems by Czapla‐Masztafiak, Joanna et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 8
X‐Ray Spectroscopy on Biological Systems
Joanna Czapla‐Masztafiak, Wojciech M. Kwiatek,
Jacinto Sá and Jakub Szlachetko
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/64953
Provisional chapter
X‐Ray Spectroscopy on Biological Systems
Joanna Czapla‐Masztafiak, Wojciech M. Kwiatek,
Jacinto Sá and Jakub Szlachetko
Additional information is available at the end of the chapter
Abstract
In the field of biological studies, next to the standard methods, new tools are offered by
contemporary  physics.  X‐ray  spectroscopic  techniques  enable  probing  electronic
structure  of  occupied  and unoccupied  states  of  studied  atom and distinguish  the
oxidation state, local geometry, and ligand type of elements that occur in biological
material. Direct analysis using X‐ray spectroscopy avoids many chemical preparation
steps that might modify biological samples. The information obtained gives us insight
into important biochemical processes all under physiological conditions. In this chapter
we focus our attention to the application of X‐ray spectroscopy to the study of biological
samples, with special emphasis on mechanisms revealing interaction between DNA and
different cytotoxic agents and in the determination of changes in oxidation state of
different elements in pathologically altered human cells and tissue.
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1. Introduction
X‐ray spectroscopy is a powerful method giving the insight into the chemical and electronic
structure of studied samples. Since twentieth century, it has been extensively used in a plethora
or research fields starting from solid‐state physics [1, 2] and followed by chemical [3] and
environmental sciences [4], archeological and art research [5], as well as biological and health
studies [6]. The advantages of this technique is its elemental specificity and high penetration
depth of probe X‐rays resulting in the possibility to undertake in situ experiments that provide
information about the sample under ambient/operational conditions, that is, direct observation
of species at  the molecular level  in low (biological)  concentrations without the need for
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preconcentration, extraction, or crystallization [7, 8]. For these reasons, X‐ray spectroscopy has
been recognized as the valuable addition to classical methods used in biological sciences and
many improvements have been made in the experimental techniques as well as data analysis
and interpretation. Research includes the simplest systems, such as single compounds, as well
as more complex and heterogeneous structures such as cells and tissues. The examples of
applications are, among others, the structural characterization of chloroperoxidase compound
I [9], the determination of ligand environment of zinc in different tissues of Zn‐hyperaccumu‐
lating plants [10] and chemical structure of metalloproteins [11]. A lot of researches concern
changes in oxidation states of trace elements in case of different pathologically altered cells and
tissues, for example the studies of differences in iron and zinc oxidation state contained in healthy
and neoplastic tissues of the human brain [12], iron in normal and stenotic human aortic valves
[13] or copper inside single neurons from Parkinson’s disease and control substantia nigra [14].
Another group of application is identification of elements’ chemical species in biological systems,
like sulfur in erythrocytes and blood plasma [15], selenium in human cancer cells [16], as well
as arsenic in various cell structures [17]. X‐ray spectroscopy gives also the opportunity to follow
biologically  relevant  processes  in  time‐resolved experiments  including the  ultrafast  time
domain. The processes studied are for example excitation of Mn cluster in photosystem II [18]
and recombination of myoglobin following the photolysis of NO [19]. The development of new
X‐ray sources and X‐ray free electron lasers (XFELs) will make possible to study the dynamics
of biological systems with femtosecond time resolution, which will elucidate the mechanisms
of many important bioprocesses.
The need for more sensitive research methods in medical sciences is forced mostly by the
increasing incidence rate of the diseases of affluence, primarily cancer and cardiovascular
diseases [20]. These types of studies are focused on two main goals—effective diagnosis on the
early stage of the disease and design of efficient therapy. This can be reached, for example, by
the discovery and validation of new biomarkers to understand the etiopathology of diseases
and by studying new, alternative treatment methods like, for example, novel potential drugs
and their interaction with the components of living cells. This review summarizes our latest
efforts in applying X‐ray spectroscopy to study different biological systems starting from the
impact of different damaging agents on the model of DNA molecule and followed by the
chemical speciation in the studies of cancerous cell lines and human tissues. Chosen topics
show the variety of medically important subjects that can be studied with X‐ray spectroscopy
and its undeniable role as a technique complementary to classical methods.
2. Principals of X‐ray spectroscopy techniques
X‐ray spectroscopic methods are atom‐specific techniques, using X‐ray excitation to gather
information about the electronic and geometric structure of the studied system. X‐rays in the
range from several to few tens of keVs are absorbed by matter mainly through the photoelectric
effect. In this process, an X‐ray photon with sufficient energy is absorbed by an electron in a
tightly bound quantum core level (such as the 1s, 2s or 2p) of an atom. A core electron is
promoted to higher, unoccupied state or to the continuum. Following an absorption event, the
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atom is in an excited state, with one of the core electron levels left empty (a core hole). During
the decay of this intermediate excited state, the core hole is filled by another inner‐ or valence‐
shell electron. The decay from the excited to the final state is accompanied by the emission of
an X‐ray photon, which energy depends on electronic levels involved in the process or by the
emission of an Auger electron or Coster‐Kroning electron. But the latter phenomenon will not
be discussed in this chapter. X‐ray absorption and X‐ray emission spectroscopy (XAS and XES,
respectively) are devoted to the study aforementioned processes. XAS provides information
about the unoccupied electronic density of states of an atom whereas XES reflects occupied
density of states, and when applied together, providing the detailed picture of the molecular
orbitals [21].
The absorption process is described by the absorption coefficient μ in the function of incidence
energy, where we can distinguish two regions—a sharp rise in absorption (an absorption edge
corresponding to the promotion of the core level electron to the higher state) and the region
above absorption edge, characterized by the rich structure. Therefore, XAS spectrum is divided
into two parts: the X‐ray absorption near‐edge structure (XANES)—typically within 30 eV of
the main absorption edge, and the extended X‐ray absorption fine‐structure (EXAFS). XAS
spectra are sensitive to the formal oxidation state, coordination chemistry, and the distances,
coordination number, and species of the atoms surrounding the selected element. K‐ and L‐
level X‐ray emission spectra, reflecting the energy distribution of photons emitted by the
atoms, can be divided into α and β regions. α lines are characterized by high transition yields
but provide little direct chemical information. On the other hand, β lines associated with
satellites are being sensitive to chemical environment of the atom, but are much weaker in
intensity. For example, two ranges may be recognized around X‐ray emission spectrum of Kβ
line: Kβ mainline consisting of metal 3p to metal 1s transitions and the valence‐to‐core (V2C
Kβ2, 5) region comprised of transitions from valence, ligand‐localized orbitals to the metal 1s.
Both have been shown to contain valuable chemical information—the Kβ mainline is sensitive
to the metal spin state as well as the metal‐ligand covalence [22] while the V2C region contains
information about ligand identity, electronic structure, and metal‐ligand bond length [23].
The more detailed information about the electronic structure of studied systems can be
obtained by the use of resonant X‐ray emission spectroscopy (RXES, also called resonant
inelastic X‐ray scattering (RIXS)) that is characterized by high sensitivity. RXES, which is
photon‐in photon‐out spectroscopy, combines X‐ray absorption and X‐ray emission informa‐
tion. RXES experiments can be performed with the use of high‐energy resolution X‐ray
spectrometers, the powerful instruments used to determine the electronic structure of matter
that have found many applications in a variety of scientific areas [24–28]. In general, X‐ray
spectrometers rely on the X‐ray dispersion by a crystal providing high‐energy resolution for
X‐ray detection. In order to access detailed information about the electronic structure of matter,
the energy resolution has to be around 0.1–5 eV in order to be comparable with the natural
lifetimes of studied electronic states of an atom [29, 30]. There are three relevant X‐ray emission
spectrometer geometries: von Hamos [31, 32], Johannson [33], and Johann [34]. In the RXES
studies presented in this review, the von Hamos‐type spectrometer has been used with
segmented analyzer crystal which disperses the photon energy along one axis and focuses the
X‐Ray Spectroscopy on Biological Systems
http://dx.doi.org/10.5772/64953
185
X‐ray photons along the other axis [35]. Setup scheme for typical RXES experiment under
physiological conditions is presented in Figure 1.
Figure 1. Schematic representation of the experimental setup used in in situ RXES experiment [7]. Reproduced by per‐
mission of The Royal Society of Chemistry.
The sample is placed at the center of the crystal curvature, and the X‐rays are imaged on either
a 1D strip detector or a 2D detector. This generates an emission spectrum in a single measure‐
ment without any detector or crystal motion. By scanning the incidence energy, one can obtain
full RXES plane. A cut in the plane performed at maximum emission energy results in high‐
resolution X‐ray absorption spectrum (HR‐XAS) that, due to reduced lifetime broadening,
provides detailed information about very small variations in the unoccupied electronic states.
The example of RXES plane measured for cisplatin compound is presented in Figure 2. It shows
the states generated by the resonant excitation of a 2p3/2 electron into the Pt 5d orbitals (L3‐edge
transition). Schematically shown horizontal and vertical cuts along the RXES plane correspond
to the Lα1 lines of the X‐ray emission spectrum (XES) and high‐resolution X‐ray absorption
spectrum (HR‐XAS) profiles, which provide information on occupied and unoccupied
electronic states of the metal, respectively.
Figure 2. Pt L3‐edge RXES map of cisplatin compound [7]. Reproduced by permission of The Royal Society of Chemis‐
try.
In parallel to the development of the experimental aspects of X‐ray spectroscopy, the significant
progress has been done in the theory and ab initio calculations of XAS and XES spectra that
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enables detailed qualitative and quantitative analysis of experiment. Among others, two
representatives of ab initio codes are FEFF9.0 [36] and FDMNES [37]. FEFF9.0, based on Green's
Function, is automated software for ab initio multiple scattering calculations of X‐ray absorp‐
tion and X‐ray emission signals and various other signals for solids, clusters, or molecules. The
code provides yields for X‐ray scattering amplitudes that may be directly compared to
measured RXES signals. Recently, code was upgraded with several new features for more
precise and more realistic calculations, which include ab initio Debye‐Waller factors, improved
treatment of inelastic loses and core‐hole interaction as well as more accurate treatment of
crystalline systems with k‐space calculations of the Green's function. Similarly, to FEFF
software, FDMNES provides yields for X‐ray scattering amplitudes that may be directly
compared to measured experimental spectra. Nevertheless, unlike FEFF, which is based on
self‐consistent spherical muffin‐tin scattering potentials, the FDMNES employs the finite
difference method (FDM) based on density functional theory (DFT) with a potential exchange
correlation depending on the local electron density. Therefore, FDMNES may provide more
accurate density of states calculations, especially for surface states, but at cost of much longer
computation times.
3. Chemical analysis of antitumor compounds
It is beyond doubt that, in case of cancerous diseases, the effective therapy is needed. The
majority of drugs used in cancer treatments are cytotoxic (cell killing) and interfere with the
cells’ DNA. Consequently, the DNA‐drug interaction mechanism is of the primary interest
when new antitumor compounds are studied. The development of new anticancer drugs is
forced by the strong side effects and chemoresistance, both being induced when commonly
used platinum‐based chemotherapeutics are applied. The binding mechanism of newly
synthesized complexes to DNA is one of the most important characteristics to be determined
for identification of drug–DNA activity. This can be probed with direct techniques, like nuclear
magnetic resonance (NMR) or crystallography. However, these approaches very often require
harsh sample preparation that may lead to difficulties in the interpretation of the results.
Therefore, simultaneously to the development of new routes of drug synthesis and studying
drug‐DNA interaction, further development of experimental techniques is necessary. Most
importantly, detailed structural and electronic information of the samples has to be retrieved
under in situ conditions with the ability to control the sample environment and mimicking real
physiological conditions.
3.1. Chemical speciation
During the phase of designing new potential antitumor compound, it is important to under‐
stand how its structure influences its activity. Especially, it is essential to apprehend why
different diastereomers of metal compounds are showing differences in reactivity that
sometimes cannot be justified by simple steric effects. In order to study the effect of stereo‐
chemistry on the electronic structure around the metal center, RXES technique was used [38].
Two chiral platinum (II) compounds [39], namely (1S,2S)‐ and (1R,2R)‐1‐(4‐fluorophenyl)‐3‐
X‐Ray Spectroscopy on Biological Systems
http://dx.doi.org/10.5772/64953
187
isopropyl‐1,2‐diaminedichloro platinum(II) (trans and cis, respectively), were studied. Cis
isomer exhibits 50‐times higher anticancer activity than the trans one [39]. Pt L3‐edge RXES
spectra of the studied samples were collected with the use of wavelength‐dispersive X‐ray
spectrometer in von Hamos geometry. The experimental setup allows the simultaneous
detection of Lα1 and valence‐to‐core (V2C) signals and therefore from obtained maps, HR‐XAS
and V2C spectra were extracted by performing cuts at RXES plane. Experimental data were
complemented with theoretical FEFF9.0 calculations of orbital contribution to the measured
signals. This approach gave us the information about the density of occupied and unoccupied
electronic states. Figure 3 presents the comparison of experimental results obtained for trans
and cis compounds.
Figure 3. Comparison of the measured HR‐XAS (top) and V2C emission (bottom) spectra between trans and cis Pt‐de‐
rivatives. Difference profile is the result of subtracting trans profile from the cis profile [38]. Reproduced by permission
of The Royal Society of Chemistry.
Calculated differential signal for both HR‐XAS and V2C spectra reveals significant differences
that can be associated with the increase of anticancer activity upon configuration inversion
from trans to cis. In case of HR‐XAS, the configuration change from trans to cis shifts the position
of the white line to higher energies and increases its intensity, which is caused by increase in
empty electronic states. This is related with the increase in the ability to form new bonds and
strengthening the formed ones. More pronounced differences can be observed in case of V2C
spectra. By analyzing the calculated orbital contributions (Figure 4), one can notice that two
distinct peaks in V2C trans spectrum are resulting from the overlap of filled states of Pt‐5d and
Cl‐2p with F‐2p states forming a shoulder. In contrast, in cis spectrum, Pt‐5d and Cl‐2p do not
overlap significantly and F‐2p orbital is shifted toward higher energy, which results in a loss
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of the shoulder and overlap of the two peaks, resolvable in case of trans spectrum. The same
analysis was performed in order to compare the effect of substitution of various ligands in the
studied compounds, and the differences in HR‐XAS and V2C spectra were also observed [38]
showing that changes in R1 and R2 positions influence Pt electronic configuration.
Figure 4. Orbital contribution for V2C emission spectra for trans and cis Pt‐derivatives [38]. Reproduced by permission
of The Royal Society of Chemistry.
As it was shown, the RXES technique is sensitive to changes of electronic structure of metal‐
lodrugs that arise not only from the changes in the structure of ligands bonded directly to the
studied atom but also from the stereochemistry of further neighbors. Therefore, high chemical
sensitivity of this method makes it ideal for the studies of anticancer drug mechanism in in
situ/in vivo conditions.
3.2. The mechanism of action of chemotherapeutic drugs
In further studies, RXES method was also used to disentangle the DNA‐drug interaction
mechanism [7]. The studies focused on well‐known cisplatin (cis‐diamminedichloroplati‐
num(II)) compound that is widely used in treating a variety of cancers such as testicular,
ovarian, head, and neck tumors [40]. Although very efficient, the use of cisplatin is still dose‐
limited by side effects and inherited or acquired resistance phenomena, only partially amended
by employment of new platinum drugs [41]. Cisplatin action mechanism was only confirmed
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via X‐ray structural analysis to lead to the formation of intrastrand cross‐links (cis‐
[Pt(NH3)2{d(GpG)‐N7(1),‐N7(2)}]) with DNA 20 years after its implementation [42, 43].
RXES experiment was performed on cisplatin samples incubated for 24 h with calf thymus
DNA. In order to follow the full mechanism of cisplatin binding, aqueous and buffer solution
(physiological serum) of the drug was also studied. The intensity of the main resonance in the
measured RXES Pt L3‐edge map depends directly on the unoccupancy values in the 5d orbitals,
which are sensitive to the type of coordinating ligand, bonding strength and angle. Thus,
changes in the structure around platinum atom can be easily detected by measuring its density
of states in the 5d orbital. In situ RXES experiment was combined with theoretical calculations
performed with FEFF9.0 code. The differential RXES maps (ΔRXES) resulting from experi‐
mental data obtained for cisplatin in aqueous and buffer solution and cisplatin incubated with
DNA are presented in Figure 5(a and b). The results are compared with theoretically calculated
spectra for different reaction pathways.
The analysis showed that the hydration of cisplatin in a buffer solution leads to the formation
of a mono‐ and a diaqua complexes (cis‐[PtCl(NH3)2(H2O)]+ and cis‐[Pt(NH3)2(H2O)2]2+,
respectively). Since both complexes induce similar changes in RXES spectra, it is difficult to
judge which of the structures is predominant. Nevertheless, other studies [44, 45] revealed that
both structures are likely to play a role in the reaction with DNA. Further, we compare the
differential RXES map resulting from the addition of calf thymus DNA to the aquated cisplatin
with calculated differences. Calculations were performed for both hydration products and
revealed that the final structure of cisplatin–DNA adduct is cis‐[Pt(NH3)2‐{d(GpG)‐N7(1),‐
N7(2)}], which means that cisplatin bonds to N(7) atoms of adjacent guanines in DNA strand,
which is consistent with X‐ray crystallography results [42, 43]. Following step in data analysis
was the extraction of HR‐XAS spectra from RXES maps at constant emission energy of ∼9443 
eV along with FEFF9.0 calculations of orbital contributions for obtained signals (see Figure 6).
Figure 5. ΔRXES maps resulting from (a) cisplatin hydration in buffer solution. The result is compared with theoretical
predictions (top) loss of two chloride ions; and (bottom) loss of a chloride ion, (b) resulting from the bonding of the
aquated cisplatin with DNA. The result is compared with theoretical predictions (top) diaqua complex + DNA; and
(bottom) monoaqua complex + DNA [7]. Reproduced by permission of The Royal Society of Chemistry.
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Figure 6. HR‐XAS extracted from the RXES maps of (top panel) cisplatin in deionized water (red); cisplatin in buffer
solution (blue); and cisplatin in buffer solution + DNA. (black). Pt 5d‐density of states orbital contribution computed
with FEFF9.0 (subsequent panels) [7]. Reproduced by permission of The Royal Society of Chemistry.
Changes in HR‐XAS signal are clearly visible and can be interpreted by the changes in the
electronic density of states of platinum and neighboring atoms. In case of hydration products,
changes are associated with the substitution of Cl ligands with water molecules that lead to
the removal of Cl p‐orbital contribution and the appearance of a contribution due to the O p‐
orbitals from the water molecules that overlap less with Pt d‐orbitals indicating weaker
bonding. In case of cisplatin‐DNA complex, HR‐XAS is reflecting strong hybridization of Pt
d‐orbitals and p‐orbitals of N(7) atoms of guanines indicating that the formed bonds are
significantly stronger than Pt‐Cl (cisplatin) and Pt‐O (mono‐ and diaqua complexes).
The presented methodology has the potential to shorten the time from drug development to
drug application by decades because the process is very sensitive and fairly quick, since it does
not require extraction and/or preconcentration. The measurements yield direct information of
bonding motifs under relevant conditions and in a time‐resolved fashion. Furthermore, the
X‐Ray Spectroscopy on Biological Systems
http://dx.doi.org/10.5772/64953
191
studies can be coupled with the most recent advance in theoretical calculations, which brings
an even further dimension when talking about drug action mechanism understanding. RXES
provides both basis and confirmation of theoretical study findings, which decreases the
computational time tremendously.
We foresee this technique applied to all sorts of systems, and cells as the targets, which is
enabled by X‐ray probe of high penetration depth and high chemical speciation. The advent
of von Hamos dispersive‐type spectrometer to follow the system and improved sample
delivery systems, such as liquid jet [46], ensures measurements under beam damage‐free
conditions.
4. Investigating DNA radiation damage
Since many years, more effort is put into the studies of the impact of radiation on human
organism. Such research is carried out both in the context of radiation protection and therapy
purposes. One of the most important biomolecules being strongly linked to biological radio‐
sensitivity is DNA, which damage may trigger cell death or genomic instability. Common
damage types caused by radiation are as follows: single‐strand breaks (SSB) and double‐strand
breaks (DSB), base damage, and DNA‐DNA and DNA‐protein cross‐links. The type and
energy of radiation determine the probability of particular kinds of DNA damage production.
The interactions of various kinds of radiation with DNA are complex, providing a spectrum
of changes that vary in number and distribution. The molecular lesions are caused by either
direct ionization/excitation of DNA or indirectly, for example, through the ionization of water
and the formation of damaging‐reactive hydroxyl radicals. Nevertheless, there are still
unanswered questions concerning the detailed mechanism of DNA damage. For instance, the
influence of low radiation doses, UV radiation, and the aspect of indirect effects is of particular
interest. The biochemical and spectroscopic methods that are commonly used in these kinds
of studies can identify the possible damage types and provide information about the timescale
for lesion formation, but they are not directly sensitive to the lesion structure. Moreover, these
methods typically involve DNA degradation, processing, staining, or labeling procedures,
which by themselves may alter the DNA damage [47]. Therefore, a new experimental approach
was proposed by us [48] in order to study changes in the molecular structure of the DNA
backbone due to the interaction with various radiation types. Using X‐ray absorption spec‐
troscopy (XAS) at the phosphorus K‐edge, the influence of radiation on both the local geometric
and electronic structure around the sugar phosphate backbone was probed. The local structure
around the P atoms in DNA is sensitive to the different forms of damage. The DNA strand
breaks are linked to bond cleavage in the DNA backbone that can produce 5′‐phosphate (5′‐
PO4), 3′‐phosphate (3′‐PO4), and 3′‐phosphoglycolate (3′‐PG) termini. Further, the formation
of photolesions such as the cyclobutane pyrimidine dimer (CPD) changes the molecular
conformation resulting in a distortion around the P atom. In Figure 7, the structure of different
damage sites is presented.
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Figure 7. (a) Chemical structure of the fragment of DNA strand. Arrows indicate the bonds that can be broken and
lead to 1: 3′‐termini; 2: 5′‐termini. (b) Structures of the four lesion types: 3′‐phosphate, 3′‐phosphoglycolate, 5′‐phos‐
phate, and CPD. Distorted PO4 groups are highlighted with orange circles, reproduced from elsewhere with permis‐
sion [48].
It is expected that various geometries are obtained depending on the form and energy of the
radiation used. In our studies, we focused on two different radiation types, namely UV‐A and
proton radiation. UV‐A (315–400 nm) is a main part of UV solar light that is considered as most
serious environmental carcinogen. Although its absorption in DNA is rather small, it pene‐
trates our skin very efficiently and can reach its deeper layers [49]. UV‐A can cause several
damage types and among them the most pronounced are single‐ and double‐strand breaks
and CPDs [50], which are produced only by UV radiation. In contrast, proton radiation
produces DNA strand breaks but no CPDs. Proton radiation is the most common particle
radiation used in cancer therapy of a variety of tumors, including those of the central nervous
system, eye, lung, breast, prostate, head, and neck, as well as sarcomas and many pediatric
cancers [51]; therefore, its detailed interaction with biomolecules has to be known.
The concept of presented studies [48] was to combine XAS experiment with theoretical
calculations in order to identify the damage types and their structure. As a model sample, calf
thymus DNA was used because its structure is almost identical with human DNA [52]. X‐ray
absorption spectra were collected for aqueous solutions of DNA irradiated with UV‐A and
protons, as well as for non‐irradiated DNA that was used as a reference sample. Next, the
spectral differences were calculated for P K‐edge spectra obtained for irradiated and non‐
irradiated DNA (Figure 8(a)).
Simultaneously, P K‐edge XAS spectra were calculated theoretically for each possible damage
type (see structures in Figure 7), using FDMNES code, and the same procedure, as in case of
experimental data, to obtain spectral differences was applied. Among others, the differences
showed changes in the intensity of main peak in case of 3′‐ and 5′‐phosphate that can be
X‐Ray Spectroscopy on Biological Systems
http://dx.doi.org/10.5772/64953
193
associated with the break in one of the C‐O bonds around PO4 group, and a shift toward higher
energies in case of CPD structure, associated with decreasing bond angle in O‐P‐O bond. Next,
experimental differences were fitted with theoretical ones. The results of the fit for UV‐A
irradiated DNA are shown in Figure 8(b). It was shown that the experimental difference can
be reconstructed by the combination of theoretical spectra of 3′‐phosphate, CPD, and 5′‐
phosphate with relative ratios 56% (±6.2%), 32% (±12%), and 12% (±6.8%), respectively. It
indicates that the major damage types are strand breaks with predominant 3′‐phosphate
termini structure. Second group of damage is the formation of CPDs, which presence confirms
direct absorption of UV‐A radiation by DNA molecule. In case of the spectra obtained for
proton‐irradiated DNA, the same analysis was performed and it revealed that protons produce
mainly 3′‐phosphate (74% ± 17.6%) and 5′‐phosphate (26% ± 19.6%) lesions. No CPDs were
detected, supportive with the fact that they are only produced by UV radiation. The results for
both irradiation types show that the bond between 5′‐carbon atom of deoxyribose and oxygen
in the phosphate group is most likely to be broken in the DNA backbone.
Figure 8. (a) (top) Phosphorus K‐edge x‐ray absorption spectra of intact and UVA‐irradiated aqueous DNA samples;
(bottom) P K‐edge XAS difference signal between the spectrum of damaged and reference DNA sample. (b) The exper‐
imental difference of P K‐edge XAS obtained for UVA‐irradiated DNA sample fitted with the theoretical spectra. Re‐
produced from elsewhere with permission [48].
The foregoing approach of determining DNA damage can be easily implemented to study the
effect of any damaging agents like various radiation types and chemical compounds. As it was
shown, XAS is sensitive to the structure of the produced damage and can provide information
about their relative ratios; therefore, it can be used in studies revealing the mechanism of
damage development. Especially, it is important to study first stages of damage formation,
since, as Boudaïffa et al. [53] suggested, “it is only through a complete understanding of such
early events in the generation of genotoxic damage that we may hope to eventually manipulate
the effects of ionizing radiation at a molecular level.” It is foreseen that the developed meth‐
odology can be used in the time‐resolved experiments on lesion formation at the X‐ray free
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electron lasers (XFELs), which give the opportunity to perform X‐ray spectroscopy studies
with ultrafast timescales.
5. Studies of changes in chemical forms of sulfur in case of prostate cancer
According to the World Health Organization, “cancer is the uncontrolled growth of cells, which
can invade and spread to distant sites of the body. Cancer can have severe health consequences
and is a leading cause of death” [20]. It comprises 13% of all deaths worldwide and among
more than 100 types of cancerous diseases, each requiring unique diagnostic and treatment;
prostate cancer is the second most common type in men [20]. As in the case of other cancerous
diseases, one of the main issues in prostate cancer research is represented by the discovery and
validation of new cancer biomarkers to understand its etiopathology for both diagnosis and
new therapies design. A biomarker of cancer can be any structural and/or functional detectable
change connected with a cancer disease in human individuals, for example, in genes, proteins,
or metabolites [54]. Ideal experimental method to identify such changes should be highly
sensitive, specific, and characterized by as minimal as possible sample manipulation. The
studies presented in this section take advantage of X‐ray spectroscopy to study sulfur species
in prostate cancer cell lines and tissue [6, 8, 55, 56]. Sulfur is a key element in human organism.
In biological systems, sulfur is present in all of its oxidation state from the reduced one (‐2) to
the most oxidized one (+6). First of all, it is a part of two amino acids—cysteine and methionine
—and their derivatives, which are building blocks of many important proteins. Further,
another important compound is the major low‐molecular‐weight thiol glutathione (GSH),
which is involved in the defense against reactive oxygen species that disrupts homeostasis as
observed in several pathological conditions [57]. In its oxidized form, sulfur is present for
example in sulfates, like chondroitin sulfate, the glucosaminoglycan (GAG) occurring in
extracellular matrix that affects proliferation and cell division during growth and differentia‐
tion of tissues. Increased expression of chondroitin sulfate is associated with the development
of malignant lesions in various tissues, and it was shown that in case of prostate cancer, it
indicates high tumor malignancy [58, 59]. Additionally, sulfenic, sulfinic, and sulfonic deriv‐
atives may be formed during severe oxidation stress that is strongly associated with cancero‐
genesis and their presence in prostate cells or their surrounding may indicate dysregulated
redox balance [60]. Because of its sensitivity, X‐ray absorption spectroscopy accompanied by
careful data analysis was applied to such a complex and heterogenic samples.
5.1. Sulfur speciation in prostate cancer cell lines
Commercially available cell lines are often used as a model sample in different cancer research.
In the first part of our experiment, three commercial prostate cancer cell lines and one non‐
cancerous cell lines were used. They were as follows: PC‐3 cell line, derived from advanced
androgen independent bone metastasized prostate cancer; DU145 cell line, derived from brain
metastasis; LNCaP (androgen‐sensitive human prostate adenocarcinoma cells), derived from
the left supraclavicular lymph node metastasis; and PZ‐HPV‐7, derived from epithelial cells
cultured from normal tissue obtained from the peripheral zone of the prostate. Sulfur K‐edge
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X‐ray absorption spectra were acquired on the paraffin‐fixed, dried layer of cells, placed on
Mylar foil. Typical spectra obtained for each cell type are presented in Figure 9(a).
All of the spectra are characterized by two strong features at energies 2472.4 and 2480.0 eV
that, after the comparison with the spectra of reference compounds [6], were identified as the
signature of reduced and oxidized forms of sulfur. Although the positions of the main features
are identical in all spectra, they differ by the intensity. Preliminary analysis performed with
the use of peak fitting method to determine the area under the peaks showed that the content
of reduced sulfur forms does not vary much between cell lines but significant differences are
present in the content of oxidized sulfur forms between cancerous and non‐cancerous cells [6,
8]. These preliminary results suggested that there might be changes in redox balance, and
therefore, the detailed analysis by linear combination fit method was performed with the use
of ATHENA software [61]. The method was used before, for example, to establish sulfur forms
in erythrocytes and plasma [15]. Experimental S K‐edge XAS spectra of prostate cells were
fitted with spectra of model sulfur‐bearing compounds that are likely to be present in human
cells. The chosen groups were as follows: amino acids, thiols, disulfides, sulfonates, and
sulfates. In case of sulfonates, two model compounds were used: taurine and cysteic acid. The
representative result of fitting procedure is shown in Figures 9(b) and 10 presents the results
of the fitting for all cell line types in the form of bar graphs together with standard deviation.
Figure 9. (a) The comparison of experimental S K‐edge XANES spectra of four different cell lines. (b) Example of ex‐
perimental sulfur K‐edge XANES spectrum (PC3 cells, dotted line) with a linear combination (solid thick line) of: 1.
amino acid, 2. thiol, 3. disulfide, 4. sulfonate (cysteic acid), 5. sulfonate (taurine), and 6. sulfate. Reproduced from else‐
where with permission [8].
In case of disulfide group, no differences were observed. There were very slight changes in
amino acids and sulfates content, and the most pronounced differences were shown in case of
thiols and sulfonates, especially between DU‐145 cells and control cells. Thiols group may be
associated mainly with reduced glutathione (GSH) and presented results for this group are
consistent with the studies of Canada et al. [62] in which it was shown that DU‐145 cells, in
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comparison with other prostate cancer cells, are characterized by the highest level of GSH.
GSH is known as a neutralizing agent of oxidizing species, produced during severe oxidative
stress that is considered as one of the major factors in development and progression of prostate
cancer [63]. The higher content might be also the indicator of active cell proliferation as it is
observed in cells with aggressive phenotype [64]. The sulfonates group consists mainly of the
metabolic products generated during the oxidation of cysteine. The other example is gluta‐
thione sulfonate (GSA) that is formed as a result of the interaction between reduced glutathione
and free radicals [65].
Figure 10. The content of the model groups of compounds in different cell lines obtained from linear combination fit.
The sulfonate content represents both cysteic acid and taurine content. The error bars were calculated as the standard
deviation of the determined mean values. Reproduced from elsewhere with permission [8].
The results obtained during the analysis of S K‐edge XAS spectra of prostate cell lines gave
insights into the potential biochemical changes that occur in cancer cells. The differences in the
content of thiols between various cancerous cell lines and non‐cancerous one may indicate a
greater free radical production in cancer cells and their increased proliferative activity. Clearly
visible is also the increase in the content of oxidized sulfur forms in case of cancer cells that
indicates the unbalanced redox status. Although it is not clear whether these differences are a
cause or consequence of malignant transformation, however, the results point out that this
process influences strongly the biochemistry of sulfur‐bearing compounds inside the cell.
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5.2. Distribution of different forms of sulfur in prostate cancer tissue
In prostate tissue, as in other tissues in human organism, we can find different types of cells
accompanied by extracellular matrix. Typical prostate is built of two main parts: prostatic
glands and stroma composed from smooth muscle cells and connective tissue. Therefore, such
a structure is far more complex than cell lines, in which all cells are of the same phenotype. To
analyze the distribution of different forms of the element of interest in tissue, XAS imaging
can be used and data need to be collected from the tissue area that covers different histological
parts. The method is based on the fact that different oxidation states of the same element can
be selectively excited by tuning the incidence energy. The generated fluorescence signal is
collected in point‐by‐point mode in the chosen sample area for each of the incidence energy.
The fraction of individual forms of the element can be extracted for each pixel by applying the
procedure described by Pickering et al. [66, 67]. The calculated relative concentrations can then
be used to generate 2D maps of the distribution of each form and compared with microscopic
image.
Our experiment [56] was performed on the tissue sections obtained during routine prostatec‐
tomies that were in a form of 15‐μm‐thick air‐dried slices placed on Mylar foil. The first step
was to measure full XAS spectra in few different points on the tissue in order to establish the
value of incidence energies that should be used in XAS imaging. The examples of spectra are
presented in Figure 11.
Figure 11. Sulfur K‐edge μ‐XANES spectra collected at different points in prostate tissue (left) together with the micro‐
scopic image of the tissue with marked measurements points (right). Spectra 1, 3, and 4 are measured in nodular part
while spectrum 2 in stroma. Reproduced from elsewhere with permission [56].
The two main features have the same energy position as the ones in prostate cancer cells.
Therefore, the scanning energies were set above these features (2473 and 2482 eV) to image
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reduced and oxidized forms of sulfur in the tissue. Additionally, scans were also performed
with energy 2477 eV, which is exciting energy of sulfur with intermediate oxidation state and
2500 eV, which excites total sulfur in the sample. The latter was used to normalize measured
fluorescence intensities for different pixels. The data for prostate cancer tissue were collected
with 10‐μm spatial resolution that was enough to analyze different histological parts. 2D
distribution maps of individual chemical forms of sulfur in three prostate cancer tissue samples
obtained from three different patients are presented in Figure 12. Maps are accompanied by
the microscopic image of the studied area.
Figure 12. Two‐dimensional maps of the distribution of individual chemical forms of sulfur in the selected areas of
three different prostate cancer tissue slices together with microscopic image with marked area of scanning. (a–c) Sam‐
ples derived from three different patients diagnosed with prostate cancer undergoing prostatectomy. Reproduced from
elsewhere with permission [56].
Based on the results, we observed that the majority of sulfur located in prostate tissue occurs
in reduced form, which is consistent with the results obtained for cell lines. This form is present
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in all histological structures but predominantly in glandular part of the tissue. In contrast, the
compounds containing sulfur with intermediate oxidation state occur in very small quantities
in studied samples and they are not correlated with the specific histological structures. Sulfur
with highest oxidation state is distributed unevenly, with higher content present in prostate
stroma. As in case of prostate cancer cells, the occurrence of highly oxidized forms of sulfur
may be the indicator of the production of oxidative derivatives of sulfur‐bearing compounds
resulting from the interaction with reactive oxygen species activity due to oxidative stress [60].
But in case of tissue structure, another source of sulfur with high oxidation state may be the
elevated concentration of chondroitin sulfate in extracellular matrix, the compound that plays
a potential role in aggressiveness of a tumor [58, 59].
Conclusions drawn from this experiment confirmed the results obtained for cell lines and
extended them with information about spatial distribution of the various forms of sulfur in
different histological parts of tissue. In case of heterogenous samples like human tissue, the
methodology applied here allows to study the distribution of various chemical species of the
same element without any chemical manipulation. In case of biologically essential elements,
the detection of changes in their biochemistry can help to elucidate the possible mechanism of
cancer development and progression.
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